Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter and full-year ended Dec. 31, 2024. Highlights and Outlook Q4 sales grew 9% to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback